Approach

Santé invests in early-stage life science and healthcare ventures to build valuable, enduring companies. We evaluate the following criteria when considering potential investment opportunities:

  • Exceptional Entrepreneurs and Executives.
    Uncompromising integrity; proven track record; relevant domain experience; complementary skill sets and diverse perspectives; intellectual honesty; ambition and energy.
  • Product or Service.
    Innovative and compelling value proposition or potential breakthrough improvement in clinical outcomes, healthcare efficiency or access; clear regulatory and reimbursement pathways.
  • Market and Customers.
    Large and/or rapidly growing market; playing into a technical or regulatory dislocation; clear evidence of customer adoption; efficient sales cycle or distribution channel; repeat purchasers.
  • Proprietary Advantage.
    Defendable intellectual property or market position; competitive barriers high enough to build significant equity value if the product or service proves successful in the market.
  • Business Model.
    Recurring revenue stream; High gross margins and operating leverage; attractive cash cycle; limited asset intensity.
  • Deal Structure.
    Fair and simple; aligned incentive among investor and management; efficient use of equity capital; attractive risk-return ratio.
  • Exit Strategy.
    Well defined with multiple logical acquirers and preferably IPO potential.
News
April 30, 2015 Mirna Therapeutics Secures $41.8 Million Series D Financing to Advance Oncology microRNA Pipeline
Read More
April 14, 2015 IBM Acquires Explorys to Accelerate Cognitive Insights for Health and Wellness
Read More